Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Pacira BioSciences
PCRX
$991M
| $27.7M | 0.04% |
888,391
+348,542
| +65% | +$12.4M |
|
|
TSRO
702
DELISTED
TESARO, Inc.
TSRO
| $27.7M | 0.04% |
484,245
+179,696
| +59% | +$11.6M |
|
|
STBZ
703
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $27.5M | 0.04% |
915,460
+221,694
| +32% | +$6.69M |
|
704
Crane NXT
CXT
$2.87B
| $27.5M | 0.04% |
852,653
+313,583
| +58% | +$10.2M |
|
|
ACC
705
DELISTED
American Campus Communities, Inc.
ACC
| $27.4M | 0.04% |
710,387
+662,965
| +1,398% | +$25M |
|
|
NUVA
706
DELISTED
NuVasive, Inc.
NUVA
| $27.3M | 0.04% |
523,391
-7,366
| -1% | -$374K |
|
707
Visteon
VC
$2.72B
| $27.2M | 0.04% |
247,152
+204,225
| +476% | +$25.5M |
|
708
Forum Energy Technologies
FET
$855M
| $27.2M | 0.04% |
+123,722
| New | +$34.5M |
|
709
Golar LNG
GLNG
$5.25B
| $27.2M | 0.04% |
993,627
+666,538
| +204% | +$18.8M |
|
710
Steven Madden
SHOO
$3.36B
| $27.2M | 0.04% |
928,188
+188,889
| +26% | +$5.71M |
|
711
Fluor
FLR
$6.86B
| $27.2M | 0.04% |
474,609
+282,699
| +147% | +$16.2M |
|
712
Emcor
EME
$33.7B
| $27.1M | 0.04% |
348,361
-48,840
| -12% | -$3.87M |
|
713
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.79B
| $27.1M | 0.04% |
192,537
+52,843
| +38% | +$7.57M |
|
714
Medifast
MED
$134M
| $27.1M | 0.04% |
289,848
+117,967
| +69% | +$8.81M |
|
|
HK
715
DELISTED
Halcon Resources Corporation
HK
| $27.1M | 0.04% |
5,561,127
+2,021,349
| +57% | +$13.7M |
|
|
MLNX
716
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $27.1M | 0.04% |
371,716
+19,019
| +5% | +$1.28M |
|
717
Teck Resources
TECK
$34.4B
| $27.1M | 0.04% |
1,051,091
-1,306,073
| -55% | -$36.8M |
|
|
GWPH
718
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $27M | 0.04% |
239,774
+41,349
| +21% | +$5.2M |
|
719
Texas Roadhouse
TXRH
$13.5B
| $27M | 0.04% |
467,283
-18,578
| -4% | -$1.07M |
|
720
WIX.com
WIX
$3.53B
| $27M | 0.04% |
339,228
+326,816
| +2,633% | +$22.9M |
|
721
Halozyme
HALO
$12.3B
| $26.9M | 0.04% |
1,373,247
-101,896
| -7% | -$1.97M |
|
722
LKQ Corp
LKQ
$6.51B
| $26.9M | 0.04% |
707,669
-573,454
| -45% | -$23.3M |
|
723
DuPont de Nemours
DD
$18.5B
| $26.8M | 0.04% |
166,312
+85,171
| +105% | +$15.4M |
|
724
Hubbell
HUBB
$24.7B
| $26.7M | 0.04% |
219,126
-165,410
| -43% | -$21.8M |
|
725
GSK
GSK
$104B
| $26.6M | 0.04% |
545,334
-915,027
| -63% | -$42.6M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.